Clearly the market is unimpressed with latest collaboration announcement.
Not what anyone expected, I think?
After the advisory of numerous enquiries to collaborate, this is disappointing.
I hope its a to prelude only to something significantly better, because if it is not, we are in trouble (imo).
Whilst better treatments are needed for soft tissue carcinoma, the world market is relatively small and tiny in Poland. It may take a long time to recruit patients, noting interim data expected end of 2024!
SP now at same level as November 2020.
Yes markets are all lower and biotech's (risk off) have taken a beating, albeit many of our peers have rebounded.
These types of collaboration happen usually once a drug/product has been approved and then bolt-on other indications that add value.
Concerned.
Clearly the market is unimpressed with latest collaboration...
-
- There are more pages in this discussion • 1,897 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 827 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 827 | 2 |
View Market Depth
| Last trade - 09.43am 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable